v3.26.1
Basis of Presentation (Details) - DiamiR Biosciences Corp. [Member]
9 Months Ended 12 Months Ended
Feb. 28, 2026
USD ($)
Feb. 28, 2025
USD ($)
May 31, 2025
USD ($)
May 31, 2024
USD ($)
Basis of Presentation [Line Items]        
Business segment unit 1      
Net loss $ (349,842)   $ (743,235) $ (614,405)
Net cash used in operating activities $ (64,162) $ (130,045) (313,440) (308,914)
Limited Operating [Member]        
Basis of Presentation [Line Items]        
Net loss     (743,235) $ (614,405)
Net cash used in operating activities     $ (313,440)